노바백스(주)
US ˙ NasdaqGS ˙ US6700024010

소개

이 페이지에서는 Margaret G Mcglynn의 공개된 내부자의 매매 거래 내역을 종합적으로 분석합니다. 내부자들은 기업의 임원(내부 경영진), 이사 또는 주요 투자자입니다. 일반적으로 내부자가 중요한 비공개 정보를 기반으로 자신이 속한 기업을 거래하는 것은 불법으로 간주됩니다. 이것은 내부자가 자신의 기업 내에서 행하는 모든 거래가 불법이라는 것을 뜻은 아닙니다. 그러나 그들은 자신들의 모든 거래를 양식 4를 통해 SEC에 보고해야만 합니다. 이러한 제한에도 불구하고, 학계 연구에 따르면 내부자는, 일반적으로, 자신의 회사 주식에 대한 실적이 시장의 수익률을 능가하는 경향성을 보였습니다.

평균 거래 수익성

평균 거래 수익성은 내부자가 지난 3년 동안 매입한 모든 "공개 시장"(Open market)에서의 매입의 평균 수익률입니다. 이를 계산하기 위해 10b5-1 거래 계획의 일부로 표시된 모든 거래를 제외하고 내부자가 계획되지 않은 모든 오픈 마켓에서의 매입을 조사합니다. 그런 다음 3개월, 6개월, 12개월 동안 해당 거래의 평균 성과를 계산하여 각 거래에 대한 최종 성과 지표를 생성합니다. 마지막으로 내부자에 대한 성과 지표를 계산하기 위해 모든 성과 지표의 평균을 내립니다. 이 목록에는 지난 2년 동안 최소 3번 이상 거래한 내부자만 포함됩니다.

내부자의 매매 거래 수익성이 "해당 없음"인 경우, 내부자는 지난 3년 동안 공개 시장에서 매수한 적이 없거나, 거래가 너무 최근에 이루어져서 신뢰할 수 있는 성과 지표를 산출할 수 없는 경우에 해당합니다.

업데이트 주기: 일별

최고 수익율의 내부자 목록을 확인하세요.

내부자 포지션이 보고된 기업

SEC 서류에 따르면 Margaret G Mcglynn 기업이 다음 기업에 대한 보유 또는 거래를 보고했습니다:

증권 소유권 최근 보고된 보유 주식
US:FOLD / Amicus Therapeutics, Inc. Director 0
US:NVAX / Novavax, Inc. Director 25,588
US:VRTX / Vertex Pharmaceuticals Incorporated Director 4,462
US:APD / Air Products and Chemicals, Inc. Director 42,814
차트 해석 방법

아래 차트는 Margaret G Mcglynn에 의한 각 "공개 시장"(Open market)에서 계획되지 않은 거래 이후 증권의 주가 실적을 보여줍니다. 계획되지 않은 거래는 10b5-1 거래 계획의 일환으로 이루어지지 않은 거래입니다. 주가 실적은 주가의 누적 백분율 변화로 표시됩니다. 예를 들어, 2019년 1월 1일 내부자의 매매 거래가 이루어졌을 경우, 차트는 현재까지 증권의 일별 백분율 변화를 보여줍니다. 이 기간 동안 주가가 10달러에서 15달러로 간다면, 주가의 누적 백분율 변화는 50%가 됩니다. 10달러에서 20달러로의 가격 변화는 100%가 되며, 10달러에서 5달러로의 가격 변화는 -50%가 됩니다.

궁극적으로 내부자의 매매 거래가 내부자의 정보를 이용하여 이익을 얻기 위해 거래 타이밍을 맞추고 있는지 확인하기 위해 내부자의 매매 거래가 주가의 초과 수익률(양 또는 음)과 얼마나 밀접한 상관 관계가 있는지 확인하고자 합니다. 내부자가 이러한 작업을 수행하고 있는 상황을 고려해 보겠습니다. 이러한 상황에서 우리는 (a) 매입 후 양의 수익률 또는 (b) 매각 후 음의 수익률을 기대할 수 있습니다. (a)의 경우, 매입 차트는 상향으로 기울어진 일련의 곡선을 보여주며, 각 매입 거래 후 양의 수익률을 나타냅니다. (b)의 경우, SALE 차트는 하향으로 기울어진 일련의 곡선을 보여주며, 각 판매 거래 후 음의 수익률을 나타냅니다.

그러나 이것만으로는 결론을 도출하기에 충분하지 않습니다. 예를 들어, 해당 기업의 주가가 수년에 걸쳐 비주기적 상승 추세에 있다면, Fintel은 매입 후 도표가 모두 상향 곡선으로 예상할 수 있습니다. 마찬가지로, 수년에 걸쳐 비주기적 하락은 거래 후에 하향 곡선으로 초래할 가능성이 높습니다. 이 도표들 중 어느 것도 내부자의 매매 거래 활동을 시사하지는 않습니다.

가장 강력한 지표는 주가가 극단적으로 순환하는 상황일 것이고, PURCHASE 차트에는 긍정적인 시그널이, SALE 차트에는 부정적인 플롯이 존재했습니다. 이는 자신들의 금전적 이익을 위한 거래 타이밍을 재던 내부자에 의한 상황일 가능성이 높습니다.

내부자 매입 NVAX / Novavax, Inc.: 단기 이익 분석

이 섹션에서는 NVAX / Novavax, Inc.에 대한 "공개 시장"(Open market)에서 계획되지 않은 내부자의 매입이 발생한 모든 상품의 수익성을 분석합니다. 이 분석은 내부자가 지속적으로 비정상적인 수익을 창출하는지 이해하는 데 도움이 되며, 이를 따를 가치가 있습니다. 이 분석은 각 거래 후 1년 동안 수행되며, 결과는 이론 값입니다.

아래 표는 사전 거래 계획(Automated trading plan)에 포함되지 않은 가장 최근의 공개 시장 매입을 보여줍니다.

거래일 티커 내부자 보고된
지분
보고된
가격
조정된
지분
조정된
가격
가격 기준 최고까지
일수
최고
가격
최고
이익 ($)
최고 수익률 (%)
이 내부자와 유가 증권의 조합과 관련하여 계획되지 않은 공개된 "공개 시장"(Open market) 거래는 없습니다.

조정 가격은 분할 조정된 가격입니다. 조정된 주식은 조정된 지분입니다.

NVAX / Novavax, Inc. Insider Trades
내부자 매매 NVAX / Novavax, Inc.: 단기 손실 분석

이 섹션에서는 NVAX / Novavax, Inc.에서 이루어진 계획되지 않은 모든 공개 시장에서의 내부자 매도의 단기 손실 회피를 분석합니다. 일관된 손실 회피 패턴은 향후 매각 거래에서 가격 하락이 발생할 수도 있다는 것을 예측할 수 있습니다. 이 분석은 각 거래 후 1년을 대상으로 한 것이며, 결과는 이론 값입니다.

아래 표는 자동 거래 계획에 포함되지 않은 가장 최근의 "공개 시장"(Open market) 매매를 보여줍니다.

거래일 티커 내부자 보고된
지분
보고된
가격
조정된
지분
조정된
가격
가격 기준 최저까지
일수
최저에서
가격
회피된
최대 손실($)
회피된
최대 손실율(%)
이 내부자와 유가 증권의 조합과 관련하여 계획되지 않은 공개된 "공개 시장"(Open market) 거래는 없습니다.

조정 가격은 분할 조정된 가격입니다. 조정된 주식은 조정된 지분입니다.

NVAX / Novavax, Inc. Insider Trades
내부자의 매매 거래 내역

아래 표는 증권거래위원회(SEC)에 공시된 Margaret G Mcglynn의 내부자의 전체 거래 목록입니다.

보고일 거래일 보고 티커 증권 코드 10b5-1 지분 잔여 지분 변동률
(%)
지분
가치
거래
가치
잔여
가치
2026-04-27 2026-04-27 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
D - Sale to Issuer -94,631 0 -100.00 14.50 -1,372,150
2025-06-16 2025-06-12 4 NVAX NOVAVAX INC
Common Stock
M - Exercise 10,420 25,588 68.70
2025-06-06 2025-06-05 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
A - Award 20,414 91,550 28.70
2025-02-05 2024-12-31 4 NVAX NOVAVAX INC
Common Stock
A - Award 1,178 15,168 8.42 8.61 10,143 130,596
2025-02-05 2024-09-30 4 NVAX NOVAVAX INC
Common Stock
A - Award 778 13,990 5.89 12.77 9,935 178,652
2025-02-05 2024-06-30 4 NVAX NOVAVAX INC
Common Stock
A - Award 713 13,212 5.70 13.93 9,932 184,043
2025-02-05 2024-03-31 4 NVAX NOVAVAX INC
Common Stock
A - Award 2,029 5,829 53.39 4.90 9,942 28,562
2024-06-14 2024-06-12 4 NVAX NOVAVAX INC
Common Stock
M - Exercise 6,670 10,470 175.53
2024-06-07 2024-06-06 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
A - Award 11,847 71,136 19.98
2024-03-06 2024-03-05 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
S - Sale -7,500 59,289 -11.23 13.40 -100,500 794,473
2024-03-06 2024-03-05 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
M - Exercise 7,500 66,789 12.65 2.80 21,000 187,009
2024-03-06 2024-03-04 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
S - Sale -7,500 59,289 -11.23 13.29 -99,675 787,951
2024-03-06 2024-03-04 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
M - Exercise 7,500 66,789 12.65 2.80 21,000 187,009
2023-06-13 2023-06-10 4 NVAX NOVAVAX INC
Common Stock
M - Exercise 3,100 3,800 442.86
2023-06-12 2023-06-08 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
A - Award 8,584 59,289 16.93
2023-01-17 2023-01-13 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
S - Sale X -15,000 50,705 -22.83 13.03 -195,387 660,473
2023-01-17 2023-01-13 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
M - Exercise 15,000 65,705 29.58 3.32 49,800 218,141
2022-06-21 2022-06-17 4 NVAX NOVAVAX INC
Common Stock
M - Exercise 700 700
2022-06-10 2022-06-09 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
A - Award 12,671 50,705 33.31
2022-05-04 2022-05-02 4 FOLD AMICUS THERAPEUTICS, INC.
Stock Options (right to buy)
D - Sale to Issuer -15,000 0 -100.00
2022-05-04 2022-05-02 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
S - Sale X -15,000 38,034 -28.28 6.99 -104,896 265,976
2022-05-04 2022-05-02 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
M - Exercise 15,000 53,034 39.44 4.79 71,850 254,033
2022-05-03 2022-05-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 4,462 4,462
2022-05-03 2022-05-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 921 5,609 19.65
2022-05-03 2022-05-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
D - Sale to Issuer -921 178 -83.80
2022-04-12 2022-04-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -5,000 5,000 -50.00
2022-04-12 2022-04-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -100 1,099 -8.34 281.49 -28,149 309,358
2022-04-12 2022-04-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -4,900 1,199 -80.34 280.19 -1,372,931 335,948
2022-04-12 2022-04-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 5,000 6,099 454.96 127.54 637,700 777,866
2022-04-04 2022-03-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock (right to buy)
M - Exercise -5,000 10,000 -33.33 127.54 -637,700 1,275,400
2022-04-04 2022-03-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1,011 1,099 -47.91 262.97 -265,863 289,004
2022-04-04 2022-03-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2,970 2,110 -58.46 262.37 -779,239 553,601
2022-04-04 2022-03-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1,019 5,080 -16.71 261.28 -266,244 1,327,302
2022-04-04 2022-03-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 5,000 6,099 454.96 127.54 637,700 777,866
2022-02-01 2022-01-28 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -5,000 15,000 -25.00 127.54 -637,700 1,913,100
2022-02-01 2022-01-28 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -212 1,099 -16.17 243.24 -51,567 267,321
2022-02-01 2022-01-28 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2,087 1,311 -61.42 242.78 -506,682 318,285
2022-02-01 2022-01-28 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -800 3,398 -19.06 241.83 -193,464 821,738
2022-02-01 2022-01-28 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1,901 4,198 -31.17 240.53 -457,248 1,009,745
2022-02-01 2022-01-28 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 5,000 6,099 454.96 127.54 637,700 777,866
2021-06-22 2021-06-17 4 NVAX NOVAVAX INC
Restricted Stock Units
A - Award 700 700
2021-06-22 2021-06-17 4 NVAX NOVAVAX INC
Stock Option (Right to Buy)
A - Award 1,300 1,300
2021-06-14 2021-06-10 4 FOLD AMICUS THERAPEUTICS, INC.
Stock Options (right to buy)
A - Award 36,111 36,111
2021-06-14 2021-06-10 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
A - Award 10,115 38,034 36.23
2021-06-03 2021-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 699 4,688 17.52
2021-06-03 2021-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
D - Sale to Issuer -699 1,099 -38.88
2021-05-05 2021-05-03 4 FOLD AMICUS THERAPEUTICS, INC.
Stock Options (right to buy)
M - Exercise -10,000 0 -100.00
2021-05-05 2021-05-03 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 27,919 -26.37 10.27 -102,704 286,739
2021-05-05 2021-05-03 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
M - Exercise 10,000 37,919 35.82 7.51 75,100 284,772
2021-05-04 2021-05-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 3,034 3,034
2021-05-04 2021-05-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 921 1,798 105.02
2020-12-09 2020-12-07 4 NVAX NOVAVAX INC
Stock Option (Right to buy)
A - Award 7,700 7,700
2020-10-01 2020-09-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 194 42,814 0.46 293.86 57,110 12,581,213
2020-08-26 2020-08-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
G - Gift -3,707 877 -80.87
2020-07-02 2020-06-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 238 42,619 0.56 238.61 56,791 10,169,388
2020-06-08 2020-06-04 4 FOLD AMICUS THERAPEUTICS, INC.
Stock Options (right to buy)
A - Award 18,574 18,574
2020-06-08 2020-06-04 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
A - Award 5,855 27,919 26.54
2020-06-03 2020-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 2,264 2,264
2020-06-03 2020-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 699 4,584 17.99
2020-04-20 2020-04-17 4 FOLD AMICUS THERAPEUTICS, INC.
Stock Options (right to buy)
M - Exercise -10,000 0 -100.00
2020-04-20 2020-04-17 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 22,064 -31.19 11.00 -110,000 242,704
2020-04-20 2020-04-17 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
M - Exercise 10,000 32,064 45.32 2.81 28,100 90,100
2020-04-02 2020-03-31 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 237 42,381 0.56 206.53 48,888 8,753,005
2020-01-24 2020-01-23 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 630 42,145 1.52 238.04 150,000 10,032,093
2020-01-10 2020-01-09 4 FOLD AMICUS THERAPEUTICS, INC.
Stock Options (right to buy)
M - Exercise -20,000 0 -100.00
2020-01-10 2020-01-09 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
S - Sale X -20,000 22,064 -47.55 10.00 -200,000 220,640
2020-01-10 2020-01-09 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
M - Exercise 20,000 42,064 90.65 3.32 66,400 139,652
2020-01-03 2019-12-31 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 204 41,514 0.49 235.33 47,921 9,769,589
2019-11-27 2019-11-26 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 3,973 41,311 10.64
2019-11-20 2019-11-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
G - Gift -239 3,885 -5.80
2019-10-24 2019-10-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -20,000 0 -100.00
2019-10-24 2019-10-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -20,000 4,124 -82.90 190.00 -3,800,000 783,560
2019-10-24 2019-10-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 20,000 24,124 484.97 72.14 1,442,800 1,740,305
2019-10-02 2019-09-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 199 37,246 0.54 221.86 44,255 8,263,348
2019-08-15 2019-08-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise 10,000 0 -100.00
2019-08-15 2019-08-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -10,000 4,124 -70.80 185.00 -1,850,000 762,940
2019-08-15 2019-08-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 10,000 14,124 242.48 81.54 815,400 1,151,671
2019-07-02 2019-07-01 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 195 37,046 0.53 226.37 44,029 8,386,172
2019-07-01 2019-06-27 4 FOLD AMICUS THERAPEUTICS, INC.
Stock Options (right to buy)
A - Award 19,473 19,473
2019-07-01 2019-06-27 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
A - Award 6,250 22,064 39.52
2019-06-04 2019-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 1,801 3,989 82.31
2019-06-04 2019-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 6,659 6,659
2019-06-04 2019-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
D - Sale to Issuer -1,801 4,124 -30.40
2019-04-02 2019-04-01 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 217 36,852 0.59 186.51 40,532 6,873,230
2019-01-25 2019-01-24 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 952 36,634 2.67 157.71 150,140 5,777,625
2019-01-02 2018-12-31 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 256 35,682 0.72 156.92 40,250 5,599,296
2018-10-01 2018-09-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 236 35,426 0.67 167.80 39,669 5,944,481
2018-07-02 2018-06-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 254 35,190 0.73 155.16 39,390 5,460,015
2018-06-11 2018-06-07 4 FOLD AMICUS THERAPEUTICS INC
Stock Options (right to buy)
A - Award 8,912 8,912
2018-06-11 2018-06-07 4 FOLD AMICUS THERAPEUTICS INC
Common Stock
A - Award 3,081 8,895 52.99
2018-06-05 2018-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 2,188 2,188
2018-06-05 2018-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 3,229 3,229
2018-06-05 2018-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
D - Sale to Issuer -2,188 5,925 -26.97
2018-06-05 2018-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 1,801 8,113 28.53
2018-05-18 2018-05-16 4 FOLD AMICUS THERAPEUTICS INC
Stock Options (right to buy)
M - Exercise -10,000 20,000 -33.33
2018-05-18 2018-05-16 4 FOLD AMICUS THERAPEUTICS INC
Common Stock
S - Sale X -10,000 15,814 -38.74 16.00 -160,000 253,024
2018-05-18 2018-05-16 4 FOLD AMICUS THERAPEUTICS INC
Common Stock
M - Exercise 10,000 25,814 63.24 3.32 33,200 85,702
2018-04-03 2018-03-31 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 208 34,936 0.60 158.18 32,972 5,526,131
2018-03-05 2018-03-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -10,000 10,000 -50.00
2018-03-05 2018-03-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -10,000 6,312 -61.30 170.00 -1,700,000 1,073,040
2018-03-05 2018-03-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 10,000 16,312 158.43 81.54 815,400 1,330,080
2018-01-29 2018-01-25 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 863 34,727 2.55 174.00 150,162 6,042,545
2018-01-24 2018-01-23 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -10,000 0 -100.00
2018-01-24 2018-01-23 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -10,000 6,217 -61.66 165.00 -1,650,000 1,025,805
2018-01-24 2018-01-23 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 10,000 16,217 160.85 59.55 595,500 965,722
2018-01-24 2018-01-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -10,000 10,000 -50.00
2018-01-24 2018-01-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -10,000 6,217 -61.66 160.00 -1,600,000 994,720
2018-01-24 2018-01-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 10,000 16,217 160.85 59.55 595,500 965,722
2018-01-02 2017-12-31 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 200 33,864 0.59 163.67 32,781 5,542,565
2017-10-02 2017-09-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 215 33,664 0.64 151.32 32,577 5,094,033
2017-07-05 2017-06-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 223 33,449 0.67 144.84 32,365 4,844,709
2017-06-16 2017-06-13 4/A FOLD AMICUS THERAPEUTICS INC
Common Stock
A - Award 5,814 15,814 58.14
2017-06-15 2017-06-13 4 FOLD AMICUS THERAPEUTICS INC
Stock Options (right to buy)
A - Award 16,236 16,236
2017-06-15 2017-06-13 4 FOLD AMICUS THERAPEUTICS INC
Common Stock
A - Award 5,814 5,814
2017-06-05 2017-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise 5,295 5,295
2017-06-05 2017-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 2,188 6,217 54.31
2017-04-04 2017-03-31 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 203 33,225 0.61 136.78 27,706 4,544,549
2017-01-27 2017-01-26 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 807 33,023 2.50 148.81 120,090 4,914,106
2017-01-04 2016-12-31 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 190 32,216 0.59 145.12 27,542 4,675,141
2016-09-30 2016-09-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 183 32,026 0.57 149.78 27,385 4,796,839
2016-07-05 2016-06-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 199 31,843 0.63 136.55 27,180 4,348,170
2016-06-13 2016-06-09 4 FOLD AMICUS THERAPEUTICS INC
Stock Options (right to buy)
A - Award 20,000 20,000
2016-06-03 2016-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 7,073 7,073
2016-06-03 2016-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 2,941 4,029 270.31 0.01 29 40
2016-04-25 2016-03-31 4/A APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 170 31,644 0.54 145.03 24,677 4,589,331
2016-03-31 2016-03-31 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 343 31,816 1.09 145.03 49,677 4,614,331
2016-01-29 2016-01-28 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 1,009 31,474 3.31 119.01 120,081 3,745,705
2016-01-05 2015-12-31 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 401 30,465 1.33 133.20 53,352 4,057,920
2015-11-20 2015-11-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -12,500 0 -100.00
2015-11-20 2015-11-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -12,500 1,088 -91.99 130.15 -1,626,875 141,603
2015-11-20 2015-11-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 12,500 13,588 1,148.90 57.27 715,875 778,185
2015-11-10 2015-11-10 4 FOLD AMICUS THERAPEUTICS INC
Common Stock
P - Purchase 10,000 10,000 10.27 102,657 102,657
2015-09-30 2015-09-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 439 30,064 1.48 125.25 54,996 3,765,557
2015-08-05 2015-08-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise 12,500 12,500
2015-08-05 2015-08-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -100 1,088 -8.42 138.98 -13,898 151,210
2015-08-05 2015-08-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2,700 1,188 -69.44 138.22 -373,194 164,205
2015-08-05 2015-08-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -6,500 3,888 -62.57 137.26 -892,190 533,667
2015-08-05 2015-08-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3,200 10,388 -23.55 136.49 -436,768 1,417,858
2015-08-05 2015-08-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 12,500 13,588 1,148.90 57.27 715,875 778,185
2015-06-30 2015-06-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 388 29,625 1.33 142.08 55,182 4,209,153
2015-06-12 2015-06-10 4 FOLD AMICUS THERAPEUTICS INC
Stock Options (right to buy)
A - Award 20,000 20,000
2015-06-03 2015-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise 7,500 0 -100.00
2015-06-03 2015-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise 5,000 25,000 25.00
2015-06-03 2015-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
A - Award 20,000 20,000
2015-06-03 2015-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -9,020 1,088 -89.24 127.53 -1,150,321 138,753
2015-06-03 2015-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3,480 10,108 -25.61 126.78 -441,194 1,281,492
2015-06-03 2015-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 7,500 13,588 123.19 53.85 403,875 731,714
2015-06-03 2015-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 5,000 6,088 459.56 57.27 286,350 348,660
2015-04-08 2015-04-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
A - Award 12,500 7,500 -250.00
2015-04-08 2015-04-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -400 1,088 -26.88 119.78 -47,912 130,321
2015-04-08 2015-04-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3,900 1,488 -72.38 118.97 -463,983 177,027
2015-04-08 2015-04-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -6,000 5,388 -52.69 118.32 -709,920 637,508
2015-04-08 2015-04-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2,200 11,388 -16.19 117.14 -257,708 1,333,990
2015-04-08 2015-04-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 12,500 13,588 1,148.90 53.85 673,125 731,714
2015-03-31 2015-03-31 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 369 29,237 1.28 152.75 56,338 4,465,928
2015-02-13 2012-08-10 5 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 15 1,088 1.40 51.23 768 55,738
2015-02-13 2011-12-07 5 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 9 1,088 0.83 29.19 263 31,759
2015-02-13 2011-12-06 5 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 33 1,088 3.13 29.66 979 32,270
2015-02-13 2011-11-22 5 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 31 1,088 2.93 28.00 868 30,464
2015-01-23 2015-01-22 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 832 28,868 2.97 144.32 120,074 4,166,233
2015-01-05 2014-12-31 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 353 28,036 1.27 147.57 52,066 4,137,276
2014-09-30 2014-09-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 414 27,683 1.52 134.77 55,748 3,730,865
2014-06-30 2014-06-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 415 27,270 1.54 128.83 53,428 3,513,136
2014-06-16 2014-06-12 4 FOLD AMICUS THERAPEUTICS INC
Stock Options (right to buy)
A - Award 15,000 15,000
2014-06-03 2014-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
A - Award 20,000 20,000
2014-04-01 2014-03-31 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 445 26,855 1.69 118.44 52,733 3,180,686
2014-01-24 2014-01-23 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 1,081 26,410 4.27 111.01 120,002 2,931,730
2014-01-03 2013-12-31 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 452 25,329 1.82 113.43 51,326 2,873,023
2013-09-30 2013-09-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 465 24,876 1.91 109.78 51,082 2,730,899
2013-07-01 2013-06-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 445 24,411 1.86 96.13 42,766 2,346,610
2013-06-17 2013-06-13 4 FOLD AMICUS THERAPEUTICS INC
Stock Options (right to buy)
A - Award 15,000 15,000
2013-06-04 2013-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
A - Award 20,000 20,000
2013-04-01 2013-03-29 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 486 23,966 2.07 86.28 41,906 2,067,780
2013-01-25 2013-01-24 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 1,361 23,480 6.15 88.23 120,081 2,071,660
2013-01-02 2012-12-31 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 483 22,119 2.23 84.80 40,955 1,875,710
2012-11-08 2012-11-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 1,000 1,000 45.50 45,500 45,500
2012-10-01 2012-09-28 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 496 21,636 2.35 83.18 41,280 1,799,704
2012-07-02 2012-06-29 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 509 21,140 2.47 76.56 38,954 1,618,478
2012-06-15 2012-06-13 4 FOLD AMICUS THERAPEUTICS INC
Stock Options (right to buy)
A - Award 15,000 15,000
2012-06-01 2012-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
A - Award 20,000 20,000
2012-03-30 2012-03-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 458 20,631 2.27 90.49 41,411 1,866,917
2012-01-27 2012-01-26 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 1,362 20,174 7.24 88.16 120,074 1,778,501
2012-01-04 2011-12-31 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 408 18,812 2.22 84.98 34,674 1,598,607
2011-05-13 3 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
0
P
공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매입
S
공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매각
A
자사로부터 유가증권(옵션 등)을 보조, 지급 또는 기타 취득
C
파생상품 전환
D
자사에게 유가증권을 매각 또는 양도
F
기업으로부터 인도 받은 유가증권의 일부를 사용한 행사 가격 또는 조세 채무의 지급
G
내부자에 의한 또는 내부자에게 증권 증여
K
지분스왑 및 유사 위험 회피거래
M
자사로부터 인도 받은 파생증권(옵션 등)의 행사 또는 전환
V
보고서 양식 4에 자진 신고된 거래
J
기타 (거래 내용을 설명하는 각주와 동반)